Antithrombotic therapy following revascularization for chronic limb-threatening ischaemia: a European survey from the ESC Working Group on Aorta and Peripheral Vascular Diseases.
Marco De CarloOliver SchlagerLucia MazzolaiMarianne BrodmannChristine Espinola-KleinDaniel StaubVictor AboyansHenrik SillesenEike Sebastian DebusMaarit A VenermoJill J F BelchMauro FerrariRaffaele De CaterinaPublished in: European heart journal. Cardiovascular pharmacotherapy (2022)
Current antithrombotic therapy of CLTI patients undergoing LER remains largely discretional, and prescription of DPI is related to reimbursement policies. An individualised assessment of thrombotic and bleeding risks is largely missing.